Exposure-safety and efficacy response relationships and population pharmacokinetics of eslicarbazepine acetate.
Barry E GidalM P JacobsonE Ben-MenachemM CarreñoD BlumP Soares-da-SilvaA FalcãoF RochaJ MoreiraT GrinnellE LudwigJ Fiedler-KellyJ PassarellS SunkaraneniPublished in: Acta neurologica Scandinavica (2018)
Pharmacokinetic and PK/PD modeling were implemented during the development of ESL for adjunctive treatment of FOS in adults. This quantitative approach supported decision-making during the development of ESL, and contributed to dosing recommendations and labeling information related to drug interactions.